February 2017
Intermediate to advanced
416 pages
14h 52m
English
For decades, tremendous efforts have been made by biomedical and pharmaceutical researchers to treat diseases affecting the central nervous system (CNS). The blood–brain barrier effectively protects the brain, but poses a formidable challenge to drug delivery. Many conventional drugs cannot cross the BBB in therapeutic concentrations (less than 1%). As a result proper treatments of various CNS diseases such as Alzheimer, brain tumors, and human immunodeficiency virus infection are compromised. ...
Read now
Unlock full access